NCT02771496 Osteochondritis Dissecans of Knee Prospective Cohort
| NCT ID | NCT02771496 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Pennsylvania |
| Condition | Osteochondritis Dissecans |
| Study Type | OBSERVATIONAL |
| Enrollment | 3,000 participants |
| Start Date | 2014-05-01 |
| Primary Completion | 2074-05-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 3,000 participants in total. It began in 2014-05-01 with a primary completion date of 2074-05-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The Cohort is a multi-site prospective data collection study that will enroll any patient with diagnosis of knee OCD (confirmed by a standard of care x-ray or MRI). Patients will be followed for up to the next 50 years of their lives to study courses of care, disease progression, treatment/surgical options/results, and specific sports-related outcomes in athletic patients. Subjects will complete quality of life surveys as part of the Cohort. Course of care will not be affected.
Eligibility Criteria
Inclusion Criteria: * Diagnosis of osteochondritis dissecans or focal articular cartilage defects as confirmed by x-ray or MRI Exclusion Criteria: * Non-confirmed diagnosis (i.e. patient does not yet have imaging confirmation)
Contact & Investigator
James L Carey, MD
PRINCIPAL INVESTIGATOR
University of Pennsylvania
Frequently Asked Questions
Who can join the NCT02771496 clinical trial?
This trial is open to participants of all sexes, studying Osteochondritis Dissecans. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT02771496 currently recruiting?
Yes, NCT02771496 is actively recruiting participants. Contact the research team at mounika.ponakala@pennmedicine.upenn.edu for enrollment information.
Where is the NCT02771496 trial being conducted?
This trial is being conducted at Philadelphia, United States.
Who is sponsoring the NCT02771496 clinical trial?
NCT02771496 is sponsored by University of Pennsylvania. The principal investigator is James L Carey, MD at University of Pennsylvania. The trial plans to enroll 3,000 participants.